Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2f5998d5bef7c644add3dc1a2c9b675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19db6075876bdab1765464497f8118c3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 |
filingDate |
2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd52e6acd3985f9be11753388b486963 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8486026b15bb021178bd92b4fded746 |
publicationDate |
2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007190617-A1 |
titleOfInvention |
DNA vaccine for Japanese encephalitis virus |
abstract |
A DNA vaccine of Japanese encephalitis virus (JEV) of the present invention comprises at least one vector encoding a membrane protein and an envelope protein gene of JEV. Furthermore, the DNA vaccine contains a cytomegalovirus early promoter sequence, an enhancer sequence, a chimeric intron, a bovine growth hormone polyadenylation sequence and a kanamycin resistant gene. The DNA vaccine can enhance antigentic stability and provide a high level of immunity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10975136-B2 |
priorityDate |
2006-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |